FFP
NVO

FourThought Financial Partners’s Novo Nordisk NVO Stock Holding History

FourThought Financial Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.43M Buy
93,399
+33,708
+56% +$1.6M 0.3% 87
2025
Q4 		$3.04M Sell
59,691
-2,856
-5% -$146K 0.26% 87
2025
Q3 		$3.47M Buy
62,547
+4,613
+8% +$270K 0.31% 82
2025
Q2 		$4M Buy
57,934
+50,120
+641% +$3.41M 0.39% 70
2025
Q1 		$543K Buy
7,814
+808
+12% +$66.7K 0.06% 175
2024
Q4 		$603K Buy
7,006
+76
+1% +$8.22K 0.06% 171
2024
Q3 		$825K Buy
6,930
+110
+2% +$14.7K 0.1% 117
2024
Q2 		$973K Sell
6,820
-56
-0.8% -$7.42K 0.13% 108
2024
Q1 		$883K Buy
6,876
+1,413
+26% +$168K 0.1% 146
2023
Q4 		$565K Sell
5,463
-98
-2% -$9.69K 0.07% 183
2023
Q3 		$506K Sell
5,561
-115
-2% -$10.1K 0.07% 182
2023
Q2 		$459K Sell
5,676
-1,574
-22% -$129K 0.06% 201
2023
Q1 		$577K Sell
7,250
-306
-4% -$21.7K 0.08% 166
2022
Q4 		$511K Buy
+7,556
New +$443K 0.07% 180

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

FourThought Financial Partners's NVO Position: Q1 2026 in Review

FourThought Financial Partners increased its Novo Nordisk (NVO) stake by 56% in Q1 2026, buying an estimated $1.6M and bringing the position to 93,399 shares worth $3.43M. The position accounts for 0.3% of the portfolio, ranked #87.

FourThought Financial Partners first reported a position in NVO in Q4 2022 and has held it in 14 quarters since. The position peaked at $4M in Q2 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • FourThought Financial Partners held 93,399 shares of Novo Nordisk worth $3.43M as of Q1 2026.
  • FourThought Financial Partners bought 33,708 Novo Nordisk shares in Q1 2026, an estimated $1.6M.
  • Novo Nordisk made up 0.3% of FourThought Financial Partners's portfolio in Q1 2026, its #87 holding.
  • FourThought Financial Partners first reported a position in Novo Nordisk in Q4 2022 and has held it in 14 quarters since.
  • FourThought Financial Partners's Novo Nordisk position peaked at $4M in Q2 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.